🇺🇸 FDA

Intelligence · Patent portfolio

Theravance Biopharma Ireland Patents

Full USPTO pharma patent portfolio for Theravance Biopharma Ireland — grant dates, expiration, and drug cross-links.

Patents
635
Expiring ≤24m
58

Quick answer

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 14

  1. US 12384761

    Imidazolo indazole compounds as JAK inhibitors

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12358931

    3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12351561

    Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12285417

    Methods for treating chronic obstructive pulmonary disease

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12258316

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12239638

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12172994

    Pyrimidine compound as JAK kinase inhibitor

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12122773

    Crystalline hydrate of a JAK inhibitor compound

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12048692

    Methods for treating chronic obstructive pulmonary disease

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12016835

    Neprilysin inhibitors

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11919888

    Neprilysin inhibitors

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11878977

    JAK inhibitors containing a 4-membered heterocyclic amide

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11858898

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11851443

    Neprilysin inhibitors

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11845747

    Ester and carbonate pyrimidine compounds as JAK kinase inhibitors

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11814377

    Pyrimidine compound as JAK kinase inhibitor

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11795180

    Formulation of a pan-JAK inhibitor

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11786517

    Methods of treatment using a JAK inhibitor compound

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11780852

    Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11730720

    ALK5 inhibitors

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11723900

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11718616

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11718591

    Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11713315

    5 to 7 membered heterocyclic amides as JAK inhibitors

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11702415

    Crystalline hydrate of a JAK inhibitor compound

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11697648

    Fused pyrimidine pyridinone compounds as JAK inhibitors

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11691948

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11673879

    Substituted pyrimidines and methods of use

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11667637

    Fused imidazo-piperidine JAK inhibitors

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11649209

    Crystalline freebase forms of a biphenyl compound

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11642339

    Methods of treating symptoms of gastroparesis using velusetrag

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11642332

    (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11634413

    Neprilysin inhibitors

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11608354

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11596624

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11590116

    Substituted pyridines and methods of use

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11548887

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11547687

    Neprilysin inhibitors

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11484531

    Methods for treating chronic obstructive pulmonary disease

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11471442

    Administration of gut-selective JAK3 inhibitor

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11453668

    JAK inhibitors containing a 4-membered heterocyclic amide

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11452723

    Combination dosage form of a mu opioid receptor antagonist and an opioid agent

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11439641

    Pyrimidine JAK inhibitors for the treatment of skin diseases

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11420965

    Pyrimidine compound as JAK kinase inhibitor

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11390603

    Crystalline forms of a biphenyl compound

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11339160

    Imidazole and triazole containing bicyclic compounds as JAK inhibitors

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11299492

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11261197

    Neprilysin inhibitors

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.